Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Full Day's HansardDownload Full Day's Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Wednesday, 10 April 1957


Mr Whitlam m asked the Minister for Health, upon notice -

1.   Did the National Health and Medical Research Council on the 24th May, 19S6, recommend that indications for the use of tetracyclines as pharmaceutical benefits under the National Health Act should include all staphylococcal infections that may reasonably be assumed to have originated in a maternity hospital?

2.   Has the Pharmaceutical Benefits Advisory Committee made a recommendation in the matter?

3.   If so, what was the date and text of the committee's recommendation?


Dr DONALD CAMERON (OXLEY, QUEENSLAND) - The answers to the honorable member's questions are as follows: -

1.   Yes.

2.   Yes.

3.   The Pharmaceutical Benefits Advisory Committee has recently made certain recommendations with regard to the use of broad-spectrum antibiotics for the treatment of staphylococcal infections, which will include staphylococcal infections assumed to have originated in a maternity hospital I have accepted these recommendations and as soon as the necessary legislative actions have been completed, these broad-spectrum antibiotics, which include the tetracyclines, will become available as general pharmaceutical benefits.







Suggest corrections